Browsing by Keywords Deucravacitinib
Showing results 1 to 1 of 1
| Preview | Issue Date | Title | Author(s) | Access |
|---|---|---|---|---|
![]() | 2023 | Deucravacitinib, a tyrosine kinase 2 pseudokinase inhibitor, protects human EndoC-βH1 β-cells against proinflammatory insults | ![]() |
.png)

